Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

COPD Assessment Test Offers Reliable Measure of QOL For Patients With Bronchiectasis

Key clinical point: The COPD Assessment Test (CAT) is a valid and easy-to-use alternative to existing health-related quality of life (QOL) questionnaires in patients with bronchiectasis.

Major finding: The test showed strong internal consistency, repeatability, and validity.

Study details: Observational, multicenter, prospective analysis of survey use in 96 patients followed for up to 1 year.

Disclosures: Praxis Pharmaceutical funded the study. The authors have no disclosures.

Citation:

De la Rosa CD et al. CHEST. 2019 Aug 22.